Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Laruelle

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 26, 2012
Combining PET biodistribution and equilibrium dialysis assays to assess the free brain concentration and BBB transport of CNS drugsRoger N Gunn, Scott G Summerfield, Cristian A Salinas, et al.
Synapse (New York, N.Y.)|December 18, 2001
NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humansLawrence S Kegeles, Diana Martinez, Lisa D Kochan, et al.
Molecular Imaging and Biology|November 15, 2011
Biodistribution and radiation dosimetry of the serotonin 5-HT₆ ligand [¹¹C]GSK215083 determined from human whole-body PETRobert A Comley, Cristian Salinas, Romina Mizrahi, et al.
Psychiatry Research|November 15, 2011
The 5-HT(2A) receptor and serotonin transporter in Asperger's disorder: A PET study with [¹¹C]MDL 100907 and [¹¹C]DASBRagy R Girgis, Mark Slifstein, Xiaoyan Xu, et al.
Biological Psychiatry|August 3, 2010
Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomographyLawrence S Kegeles, Mark Slifstein, Xiaoyan Xu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2004
Quantitative analysis of (-)-N-(11)C-propyl-norapomorphine in vivo binding in nonhuman primatesDah-Ren Hwang, Rajesh Narendran, Yiyun Huang, et al.
Synapse (New York, N.Y.)|March 2, 2011
Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine releaseRajesh Narendran, N Scott Mason, Chi-Min Chen, et al.
Synapse (New York, N.Y.)|May 28, 2010
Positron emission tomography imaging of dopamine D₂/₃ receptors in the human cortex with [¹¹C]FLB 457: reproducibility studiesRajesh Narendran, N Scott Mason, Maureen A May, et al.
Archives of General Psychiatry|March 3, 2010
Increased synaptic dopamine function in associative regions of the striatum in schizophreniaLawrence S Kegeles, Anissa Abi-Dargham, W Gordon Frankle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 2, 2014
Adenosine 2A receptor occupancy by tozadenant and preladenant in rhesus monkeysOlivier Barret, Jonas Hannestad, David Alagille, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 26, 2012
Combining PET biodistribution and equilibrium dialysis assays to assess the free brain concentration and BBB transport of CNS drugsRoger N Gunn, Scott G Summerfield, Cristian A Salinas, et al.
Synapse (New York, N.Y.)|December 18, 2001
NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humansLawrence S Kegeles, Diana Martinez, Lisa D Kochan, et al.
Molecular Imaging and Biology|November 15, 2011
Biodistribution and radiation dosimetry of the serotonin 5-HT₆ ligand [¹¹C]GSK215083 determined from human whole-body PETRobert A Comley, Cristian Salinas, Romina Mizrahi, et al.
Psychiatry Research|November 15, 2011
The 5-HT(2A) receptor and serotonin transporter in Asperger's disorder: A PET study with [¹¹C]MDL 100907 and [¹¹C]DASBRagy R Girgis, Mark Slifstein, Xiaoyan Xu, et al.
Biological Psychiatry|August 3, 2010
Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomographyLawrence S Kegeles, Mark Slifstein, Xiaoyan Xu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2004
Quantitative analysis of (-)-N-(11)C-propyl-norapomorphine in vivo binding in nonhuman primatesDah-Ren Hwang, Rajesh Narendran, Yiyun Huang, et al.
Synapse (New York, N.Y.)|March 2, 2011
Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine releaseRajesh Narendran, N Scott Mason, Chi-Min Chen, et al.
Synapse (New York, N.Y.)|May 28, 2010
Positron emission tomography imaging of dopamine D₂/₃ receptors in the human cortex with [¹¹C]FLB 457: reproducibility studiesRajesh Narendran, N Scott Mason, Maureen A May, et al.
Archives of General Psychiatry|March 3, 2010
Increased synaptic dopamine function in associative regions of the striatum in schizophreniaLawrence S Kegeles, Anissa Abi-Dargham, W Gordon Frankle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 2, 2014
Adenosine 2A receptor occupancy by tozadenant and preladenant in rhesus monkeysOlivier Barret, Jonas Hannestad, David Alagille, et al.
Pageof 11